BB Biotech AG (BB Biotech AG) Cash Receipts from Fees and Commissions : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is BB Biotech AG Cash Receipts from Fees and Commissions?

BB Biotech AG's Cash Receipts from Fees and Commissions for the three months ended in Dec. 2023 was $0.00 Mil.

BB Biotech AG's Cash Receipts from Fees and Commissions for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

BB Biotech AG Cash Receipts from Fees and Commissions Historical Data

The historical data trend for BB Biotech AG's Cash Receipts from Fees and Commissions can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Cash Receipts from Fees and Commissions Chart

BB Biotech AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Receipts from Fees and Commissions

Get a 7-Day Free Trial

BB Biotech AG Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Receipts from Fees and Commissions	Get a 7-Day Free Trial															-	-	-	-	-

BB Biotech AG Cash Receipts from Fees and Commissions Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Receipts from Fees and Commissions represents cash received from agency fees and commissions in operating cash flow, using the direct method. This item is usually only available for bank industry.

Cash Receipts from Fees and Commissions for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

BB Biotech AG Cash Receipts from Fees and Commissions Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Cash Receipts from Fees and Commissions provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG (BB Biotech AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » Cash Receipts from Fees and Commissions

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany BION:Switzerland

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (BB Biotech AG) Headlines

No Headlines